Thrombosis
From the Journals
Updates on treatment/prevention of VTE in cancer patients
“Because patients with cancer have a baseline increased risk of VTE, compared with patients without cancer, the combination of both COVID-19 and...
News from the FDA/CDC
Long COVID doubles risk of some serious outcomes in children, teens
“Many of these conditions were rare or uncommon among children in this analysis, but even a small increase in these conditions is notable.”
Guidelines
SCAI issues guidelines for PFO management, makes case for expansion
Clinical guidelines address expanded indications for percutaneous patent foramen ovale closure along with antiplatelet and anticoagulation therapy...
Guidelines
Updated AHA/ASA guideline changes care for spontaneous intracerebral hemorrhage
Several “standard care” therapies for ICH are not as effective as once thought and are no longer recommended in updated guidelines.
From the Journals
Cancer patients unaware of their increased thrombosis risk
“These professionals are on the front line of the battle; they are among the first healthcare workers given the chance to suspect a clot and...
Conference Coverage
Stroke in the young: Cancer in disguise?
“Stroke in the young differs from stroke in older patients, and one of the major differences is that stroke in the young has a higher proportion...
News
FDA limits use of J&J COVID vaccine over blood clot risk
“We recognize that the Janssen COVID-19 vaccine still has a role in the current pandemic response in the United States and across the global...
From the Journals
Traumatic brain injury linked to ‘striking’ risk for CVD, diabetes, brain disorders
Mild and moderate-to-severe TBI is linked to an increased risk for hypertension, stroke, diabetes, as well as neurological and psychiatric...
Conference Coverage
Anticoagulation not routinely needed after TAVR: ADAPT-TAVR
The ADAPT-TAVR trial showed a numerical reduction in leaflet thrombosis with edoxaban versus dual-antiplatelet therapy, but no reduction in...
From the Journals
Silver lining emerges for embolic protection in post-TAVR stroke
A database study found that embolic protection during transcatheter aortic valve replacement may improve outcomes, although not the occurrence, of...
News
FDA approves first drug for myelofibrosis with thrombocytopenia
Treatment option is the first for patients who have myelofibrosis with low platelet counts.